Stroke Research and Treatment / 2018 / Article / Tab 2

Clinical Study

Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study

Table 2

Primary endpoint occurrences.

ASA n=36controls n=47

n (%)n (%)p-value (Fisher Exact)
New SBIs1 (2.8)6 (12.8)0.103
Stroke1 (2.8)2 (4.3)
TIA-1 (2.1)
No CV events34 (94.4)38 (80.9)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.